Search

everythinglearnresearchcommunity

for

Search:↓

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Male hormones affect oil-producing skin cells differently based on their body location, and the drug spironolactone can reduce these effects.

Testosterone increases muscle mass regardless of DHT conversion blocking.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

Women with myotonic dystrophy might get diseases related to male hormones because their body tissues are extra sensitive to these hormones.

Beard cells, unlike scalp cells, produce growth factors in response to testosterone, which may explain differences in hair growth.

Mouse hair cells respond to male hormones by growing less, and this can be stopped by certain blockers.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

Knowing how skin works and its diseases helps doctors diagnose and treat skin conditions better.

Cyproterone acetate improves skin symptoms and quality of life in women with androgen-related issues.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

The osteopontin gene is active in a specific part of rat hair follicles during a certain hair growth phase and might affect hair cycle and diseases.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

The meeting presented new findings on hair stem cells, pigmentation, genetics, and modern hair treatment techniques.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Improving skin barrier function is crucial for better acne treatment.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Combination therapies work better than single treatments for atrophic acne scars.

Hidradenitis suppurativa improves with antiandrogen therapy.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Testosterone conversion to 5α-DHT may not be essential for its effects on the skin.

The study created a new method to test drugs that affect hormone processing in skin.

Effective acne treatments should reduce sebum, bacteria, and inflammation, with isotretinoin being the best for severe cases.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.